SynBiotic SE (SBX.DE) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-39390.4%

-€58.94

vs €0.15 price

Levered DCF

-€72.72

After debt service

Piotroski score

—

Altman Z-score

—

Rating

—

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-2.53×	-1.32×	-1.77×	-7.12×	-38.91×	-414.73×	-42,800×
P/B	1.07×	0.89×	1.91×	2.59×	1.34×	23.61×	134.12×
P/S	1.72×	3.63×	5.29×	10.48×	6.25×	0×	0×
EV / EBITDA	-14.57×	-2.47×	-1.91×	-7.23×	-39.68×	-413.46×	-40,655.94×
Gross margin	34.0%	39.0%	43.7%	55.3%	68.2%	0.0%	0.0%
Operating margin	-73.7%	-284.8%	-304.9%	-132.2%	-13.2%	0.0%	0.0%
Net margin	-67.9%	-275.3%	-298.4%	-147.1%	-16.2%	0.0%	0.0%
Current ratio	0.44×	0.81×	1.4×	1.46×	0.84×	95.3×	0×
Debt / equity	0.24×	0.23×	0.2×	0.1×	0.01×	0×	0×
Interest coverage	-24.58×	-56.33×	-131.79×	-245.17×	-31.51×	0×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-42.5%	-67.3%	-107.8%	-36.4%	-3.5%	-5.7%	-0.3%
Return on invested capital	-33.9%	-39.3%	-69.1%	-20.8%	-2.8%	-5.7%	0.0%
Return on assets	-21.3%	-30.4%	-60.0%	-21.0%	-2.5%	-5.6%	-0.3%
Free cash flow yield	-3.0%	-21.0%	-17.3%	-6.1%	-10.0%	-0.0%	0.0%
Earnings yield	-39.6%	-75.9%	-56.4%	-14.0%	-2.6%	-0.2%	-0.0%
Enterprise value	€29.5M	€17.6M	€46.7M	€90.9M	€28.4M	€5.6M	€33.4M
Net debt / EBITDA	-2.45×	-0.5×	-0.14×	-0.02×	7.85×	0.99×	0×
Cash conversion cycle (days)	-106	126	127	149	31	0	0